Symbols / TIVC Stock $1.40 +0.00% Valion Bio, Inc.

Healthcare • Medical Devices • United States • NCM
TIVC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Michael Kevin Handley
Exch · Country NCM · United States
Market Cap 4.03M
Enterprise Value -3.28M
Income -7.99M
Sales —
FCF (ttm) -4.29M
Book/sh 6.65
Cash/sh 4.39
Employees 52
Insider 10d —
IPO Nov 11, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.06
PEG —
P/S —
P/B 0.21
P/C —
EV/EBITDA 0.42
EV/Sales —
Quick Ratio 19.57
Current Ratio 20.13
Debt/Eq 38.42
LT Debt/Eq —
EPS (ttm) -6.92
EPS next Y -24.00
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-14
Earnings (prior) 2023-11-14
ROA -28.69%
ROE -82.69%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 2.88M
Shs Float 2.52M
Insider Own 1.46%
Instit Own 8.01%
Short Float 2.25%
Short Ratio 0.78
Short Interest 63.93K
52W High 5.60
vs 52W High -75.00%
52W Low 0.72
vs 52W Low 93.91%
Beta 1.84
Impl. Vol. —
Rel Volume 1.00
Avg Volume 262.78K
Volume 263.29K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.40
Price $1.40
Change 0.00%
About

Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.40
Latest analyst target
3. DCF / Fair value
$-26.85
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.40
Low
—
High
—
Mean
—
News
RSS: Latest TIVC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 BOLTON SHERYLE J Director — 10,000 $1.04 $10,400
2026-04-01 VALAURI CHRISTINA RIZOPOULOS Director — 19,000 $0.95 $18,008
2026-03-18 WOLF LISA G Chief Financial Officer — 92 — —
2026-02-18 HANDLEY MICHAEL K Chief Operating Officer — 8,824 — —
2025-12-18 WOLF LISA G Chief Financial Officer — 736 — —
2025-12-18 ERNST JENNIFER Chief Executive Officer — 14,706 — —
2025-09-22 ERNST JENNIFER Chief Executive Officer — 22,541 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
1.18
-36.09%
1.84
Operating Revenue
0.00
0.00
-100.00%
1.18
-36.09%
1.84
Cost Of Revenue
—
0.78
-12.49%
0.89
-42.31%
1.54
Reconciled Cost Of Revenue
—
0.78
-12.49%
0.89
-42.31%
1.54
Gross Profit
—
0.00
-99.30%
0.29
-4.01%
0.30
Operating Expense
7.90
+76.45%
4.48
-47.54%
8.53
-17.94%
10.40
Research And Development
3.13
+138.46%
1.31
-20.66%
1.66
-4.34%
1.73
Selling General And Administration
4.77
+50.71%
3.16
-54.01%
6.88
-20.65%
8.67
Selling And Marketing Expense
—
1.19
-44.14%
2.12
-23.89%
2.79
General And Administrative Expense
4.77
+50.71%
3.16
-33.44%
4.75
-19.11%
5.88
Other Gand A
4.77
+50.71%
3.16
-33.44%
4.75
-19.11%
5.88
Total Expenses
7.90
+76.45%
4.48
-52.49%
9.42
-21.08%
11.94
Operating Income
-7.90
-76.45%
-4.48
+45.71%
-8.24
+18.35%
-10.10
Total Operating Income As Reported
-7.90
-76.45%
-4.48
+45.71%
-8.24
+18.35%
-10.10
EBITDA
-7.84
-90.43%
-4.12
+48.93%
-8.06
+18.75%
-9.92
Normalized EBITDA
-7.87
-91.11%
-4.12
+48.93%
-8.06
+18.75%
-9.92
Reconciled Depreciation
0.01
-98.58%
0.35
+93.41%
0.18
+4.60%
0.17
EBIT
-7.85
-75.55%
-4.47
+45.79%
-8.24
+18.35%
-10.10
Total Unusual Items
0.03
—
—
0.00
Total Unusual Items Excluding Goodwill
0.03
—
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-8.88
-56.99%
-5.66
+31.40%
-8.24
+18.34%
-10.10
Pretax Income
-7.99
-78.81%
-4.47
+45.78%
-8.24
+18.34%
-10.10
Net Non Operating Interest Income Expense
-0.12
-2150.00%
0.01
+500.00%
0.00
-50.00%
0.00
Interest Expense Non Operating
0.15
0.00
—
—
Net Interest Income
-0.12
-2150.00%
0.01
+500.00%
0.00
-50.00%
0.00
Interest Expense
0.15
0.00
—
—
Interest Income Non Operating
0.02
+283.33%
0.01
+500.00%
0.00
-50.00%
0.00
Interest Income
0.02
+283.33%
0.01
+500.00%
0.00
-50.00%
0.00
Other Income Expense
0.03
—
—
—
Other Non Operating Income Expenses
—
—
—
—
Gain On Sale Of Security
0.03
—
—
—
Tax Provision
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.88
-56.99%
-5.66
+31.40%
-8.24
+18.34%
-10.10
Net Income From Continuing Operation Net Minority Interest
-7.99
-78.81%
-4.47
+45.78%
-8.24
+18.34%
-10.10
Net Income From Continuing And Discontinued Operation
-8.88
-56.99%
-5.66
+31.40%
-8.24
+18.34%
-10.10
Net Income Continuous Operations
-7.99
-78.81%
-4.47
+45.78%
-8.24
+18.34%
-10.10
Net Income Discontinuous Operations
-0.89
+25.32%
-1.19
—
—
Normalized Income
-8.02
-79.44%
-4.47
+45.78%
-8.24
+18.34%
-10.10
Net Income Common Stockholders
-8.88
-56.99%
-5.66
+31.40%
-8.24
+18.34%
-10.10
Diluted EPS
—
-19.68
+88.87%
-176.80
+90.00%
-1,768.00
Basic EPS
—
-19.68
+88.87%
-176.80
+90.00%
-1,768.00
Basic Average Shares
—
0.29
+516.01%
0.05
+720.00%
0.01
Diluted Average Shares
—
0.29
+516.01%
0.05
+720.00%
0.01
Diluted NI Availto Com Stockholders
-8.88
-56.99%
-5.66
+31.40%
-8.24
+18.34%
-10.10
Total Other Finance Cost
—
—
—
-0.00
Line Item Trend 2023-12-31
Total Assets
5.16
Current Assets
4.65
Cash Cash Equivalents And Short Term Investments
3.40
Cash And Cash Equivalents
3.40
Receivables
0.17
Accounts Receivable
0.17
Gross Accounts Receivable
—
Allowance For Doubtful Accounts Receivable
—
Inventory
0.76
Raw Materials
0.75
Work In Process
0.00
Finished Goods
0.04
Prepaid Assets
—
Current Deferred Assets
0.00
Assets Held For Sale Current
—
Other Current Assets
0.33
Total Non Current Assets
0.51
Net PPE
0.47
Gross PPE
0.51
Accumulated Depreciation
-0.04
Properties
0.00
Buildings And Improvements
0.35
Machinery Furniture Equipment
0.01
Other Properties
0.15
Goodwill And Other Intangible Assets
—
Other Intangible Assets
—
Non Current Deferred Assets
0.00
Other Non Current Assets
0.03
Total Liabilities Net Minority Interest
1.58
Current Liabilities
1.40
Payables And Accrued Expenses
1.21
Payables
0.87
Accounts Payable
0.71
Current Accrued Expenses
0.34
Total Tax Payable
0.16
Current Debt And Capital Lease Obligation
0.19
Current Capital Lease Obligation
0.19
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
0.18
Liabilities Heldfor Sale Non Current
—
Long Term Debt And Capital Lease Obligation
0.18
Long Term Debt
—
Long Term Capital Lease Obligation
0.18
Other Non Current Liabilities
—
Preferred Securities Outside Stock Equity
—
Stockholders Equity
3.58
Common Stock Equity
3.58
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.09
Ordinary Shares Number
0.09
Treasury Shares Number
0.00
Additional Paid In Capital
41.47
Retained Earnings
-37.89
Total Equity Gross Minority Interest
3.58
Total Capitalization
3.58
Working Capital
3.25
Invested Capital
3.58
Total Debt
0.37
Capital Lease Obligations
0.37
Net Tangible Assets
3.58
Tangible Book Value
3.58
Derivative Product Liabilities
—
Inventories Adjustments Allowances
-0.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.00
-22.25%
-5.72
+32.73%
-8.51
+4.57%
-8.92
Cash Flow From Continuing Operating Activities
-6.62
-30.24%
-5.08
+40.29%
-8.51
+4.57%
-8.92
Cash From Discontinued Operating Activities
-0.38
+40.90%
-0.64
—
—
Net Income From Continuing Operations
-7.99
-78.81%
-4.47
+45.78%
-8.24
+18.34%
-10.10
Depreciation Amortization Depletion
0.01
-98.58%
0.35
+93.41%
0.18
+4.60%
0.17
Depreciation
0.01
-98.58%
0.35
+93.41%
0.18
+4.60%
0.17
Depreciation And Amortization
0.01
-98.58%
0.35
+93.41%
0.18
+4.60%
0.17
Other Non Cash Items
0.24
—
—
—
Stock Based Compensation
0.56
+146.29%
0.23
-15.50%
0.27
-31.91%
0.40
Provisionand Write Offof Assets
—
0.35
+1006.25%
0.03
0.00
Asset Impairment Charge
0.14
0.00
—
—
Operating Gains Losses
-0.03
—
—
—
Gain Loss On Investment Securities
-0.03
—
—
—
Change In Working Capital
0.45
+137.89%
-1.19
-58.64%
-0.75
-224.30%
0.60
Change In Receivables
—
0.10
+256.72%
-0.07
-6800.00%
0.00
Changes In Account Receivables
—
0.10
+256.72%
-0.07
-6800.00%
0.00
Change In Inventory
—
0.08
+10.67%
0.07
+117.28%
-0.43
Change In Prepaid Assets
0.08
+0.00%
0.08
+184.78%
-0.09
-116.49%
0.56
Change In Payables And Accrued Expense
0.37
+139.96%
-0.94
-84.62%
-0.51
-178.85%
0.64
Change In Accrued Expense
0.23
+167.53%
-0.35
-437.86%
0.10
-5.50%
0.11
Change In Payable
0.14
+123.64%
-0.59
+3.61%
-0.61
-214.23%
0.53
Change In Account Payable
0.14
+123.64%
-0.59
+3.61%
-0.61
-214.23%
0.53
Change In Other Current Assets
0.00
-100.00%
0.03
0.00
-100.00%
0.01
Change In Other Current Liabilities
0.00
+100.00%
-0.37
-129.19%
-0.16
+9.55%
-0.18
Investing Cash Flow
-0.70
0.00
+100.00%
-0.12
-972.73%
-0.01
Cash Flow From Continuing Investing Activities
-0.70
0.00
+100.00%
-0.12
-972.73%
-0.01
Net PPE Purchase And Sale
-0.04
0.00
+100.00%
-0.12
-972.73%
-0.01
Purchase Of PPE
-0.04
0.00
+100.00%
-0.12
-972.73%
-0.01
Capital Expenditure
-0.58
—
-0.12
-972.73%
-0.01
Net Investment Purchase And Sale
-0.12
0.00
—
—
Purchase Of Investment
-0.12
0.00
—
—
Net Intangibles Purchase And Sale
-0.54
0.00
—
—
Purchase Of Intangibles
-0.54
0.00
—
—
Financing Cash Flow
18.35
+323.52%
4.33
-49.08%
8.51
+1711.17%
-0.53
Cash Flow From Continuing Financing Activities
18.35
+323.52%
4.33
-49.08%
8.51
+1711.17%
-0.53
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
2.34
-46.66%
4.38
-48.50%
8.51
0.00
Proceeds From Stock Option Exercised
0.11
0.00
0.00
-100.00%
0.06
Net Other Financing Charges
-0.31
-528.57%
-0.05
—
-0.58
Changes In Cash
10.64
+864.03%
-1.39
-1041.80%
-0.12
+98.71%
-9.46
Beginning Cash Position
2.00
-41.03%
3.40
-3.47%
3.52
-72.89%
12.97
End Cash Position
12.64
+531.62%
2.00
-41.03%
3.40
-3.47%
3.52
Free Cash Flow
-7.58
-32.40%
-5.72
+33.65%
-8.63
+3.37%
-8.93
Interest Paid Supplemental Data
—
—
—
—
Income Tax Paid Supplemental Data
—
—
—
—
Common Stock Issuance
2.34
-46.66%
4.38
-48.50%
8.51
0.00
Issuance Of Capital Stock
18.55
+323.33%
4.38
-48.50%
8.51
0.00
Net Preferred Stock Issuance
16.21
0.00
—
—
Preferred Stock Issuance
16.21
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category